International Name: NitroMed, Inc., Lexington, Massachusetts, United States
Brand / Trade Name: NitroMed
Registered country: United States
Address: Massachusetts
Established year: 1987
Description:
Former US pharmaceutical company (1987-2009) that developed BiDil, the first FDA-approved race-specific drug, for congestive heart failure; ceased operations in 2009.
Leave your rating & comment